Pharma marketing agency in Australia — TGA-clean, APVMA-aware, Medicines Australia Code-safe

Why Australian pharma teams choose Ichelon

Australian pharma marketing runs inside a tighter regulatory frame than most local generalist agencies operate under. The Therapeutic Goods Advertising Code, the Medicines Australia Code of Conduct edition currently in force, the APVMA MRL requirements for animal-health lines, and the Prices Disclosure obligations for PBS-listed products together define what a legal pharma campaign can say — and to whom. A campaign that misclassifies a Schedule 4 as an over-the-counter, or promotes a Restricted Representation without approval, is not a small compliance slip; it triggers TGA enforcement and, if the sponsor sits under Medicines Australia, a Code Committee referral.

Ichelon Australia runs pharma work with a compliance-first drafting model. Every asset — the HCP-facing detail aid, the OTC search ad, the disease-awareness campaign, the corporate-communication microsite — is written to a claim library that references the ARTG entry, the current PI/CMI, and the specific advertising channel the asset will run on. Consumer-facing therapeutic claims are pre-cleared against the TGA code section that applies to the Schedule; HCP-facing claims are pre-cleared against Medicines Australia Section 4; and animal-health claims are pre-cleared against the APVMA label. Nothing goes live until the medical, regulatory and legal reviewers have signed a versioned copy log.

The second reason is delivery economics. Pharma-brand teams in Australia typically split budget between a local creative agency for HCP campaigns and a media buyer for OTC search. Ichelon consolidates the operational layer — content, technical SEO, paid search, HCP demand mapping, medical-education video — into one accountable stack, delivered from an India base with Ichelon Australia leadership in Greater Western Sydney. The saving does not come from junior staff on the file; it comes from a leaner operating model that keeps senior strategist hours on the account without carrying Sydney-CBD overhead.

The third reason is measurement discipline. Pharma marketing suffers from an attribution gap — the doctor prescribes, the pharmacy dispenses, and the manufacturer sees the sale weeks later without knowing which campaign touched the HCP. Ichelon closes the gap where possible: HCP-portal login attribution, medical-rep coverage cross-referenced with digital touchpoints, and PBS-scripts data (where the sponsor licenses it) modelled against campaign flights. AI Share of Voice tracking answers a different question — how often does the brand appear when an HCP or patient asks ChatGPT, Perplexity or Google AI Overviews about the condition.

What Ichelon delivers for AU pharma

Serving pharma teams across Australia

Ichelon Australia works with pharma teams headquartered in Sydney North Shore, Melbourne inner east and Brisbane Fortitude Valley, plus distributor networks across every state and territory.

First 90 days on an Ichelon Australia pharma retainer

Three ways to start with Ichelon Australia pharma